ARCHIVES

Degarelix Active In Phase II Trial In Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 10 | October 29, 2004

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: FDA begins search for director of new Office of Oncology Drug Products.

October 8, 2004

Guest Editorial By ACS Chief Medical Officer Otis Brawley: ACS Revises Process for Making Guidelines

January 13, 2012

Conferees Agree On $815 Million For NCI In ‘77

July 30, 1976

NSABP Executive Committee Joins Fisher In Suit Against Pitt

August 5, 1994

Letter: No Intent To Link Flags With NSABP Inquiry, ORI’s Bivens Writes

March 10, 1995

Arimidex Gets Full Approval For HR+ Early Breast Cancer

September 30, 2005